{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:48:39Z","timestamp":1790034519133,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03115"],"award-info":[{"award-number":["22H03115"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Mycobacterium intracellulare<\/jats:italic> is a major etiological agent of <jats:italic>Mycobacterium avium-intracellulare<\/jats:italic> pulmonary disease (MAC-PD). However, the characteristics of the virulence of <jats:italic>M. intracellulare<\/jats:italic> and the in vivo chemotherapeutic efficacy remain unclear. In this study, we examined the virulence of nine <jats:italic>M. intracellulare<\/jats:italic> strains with different clinical phenotypes and genotypes in C57BL\/6 mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We classified three types of virulence phenotypes (high, intermediate, and low) based on the kinetics of the bacterial load, histological lung inflammation, and neutrophilic infiltration. High virulence strains showed more severe neutrophilic infiltration in the lungs than intermediate and low virulence strains, with 6.27-fold and 11.0-fold differences of the average percentage of neutrophils in bronchoalveolar lavage fluid, respectively. In particular, the high virulence strain M.i.198 showed the highest mortality in mice, which corresponded to the rapid progression of clinical disease. In mice infected with the drug-sensitive high virulence strain M019, clarithromycin-containing chemotherapy showed the highest efficacy. Monotherapy with rifampicin exacerbated lung inflammation with increased lymphocytic and neutrophilic infiltration into the lungs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The virulence phenotypes of clinical strains of <jats:italic>M. intracellulare<\/jats:italic> were diverse, with high virulence strains being associated with neutrophilic infiltration and disease progression in infected mice. These high virulence strains were proposed as a useful subject for in vivo chemotherapeutic experiments.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12866-023-02831-y","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:19:13Z","timestamp":1680517153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Virulence of Mycobacterium intracellulare clinical strains in a mouse model of lung infection \u2013 role of neutrophilic inflammation in disease severity"],"prefix":"10.1186","volume":"23","author":[{"given":"Yoshitaka","family":"Tateishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Maekura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohkichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"2831_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","volume":"185","author":"J Adjemian","year":"2012","unstructured":"Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries. Am J Respir Crit Care Med. 2012;185:881\u20136.","journal-title":"Am J Respir Crit Care Med."},{"key":"2831_CR2","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3201\/eid2206.151086","volume":"22","author":"H Namkoong","year":"2016","unstructured":"Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease in Japan. Emerg Infect Dis. 2016;22:1116\u20137.","journal-title":"Emerg Infect Dis"},{"key":"2831_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.resinv.2017.11.001","volume":"56","author":"K Suzuki","year":"2018","unstructured":"Suzuki K, Kurashima A, Tatsuno K, Kadota J. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance. Respir Investig. 2018;56:87\u201393.","journal-title":"Respir Investig"},{"key":"2831_CR4","doi-asserted-by":"publisher","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","volume":"56","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J. 2020;56:2000535.","journal-title":"Eur Respir J"},{"key":"2831_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS\/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"key":"2831_CR6","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3390\/jcm9051315","volume":"9","author":"K Fukushima","year":"2020","unstructured":"Fukushima K, Kitada S, Abe Y, Yamamoto Y, Matsuki T, Kagawa H, et al. Long-term treatment outcome of progressive Mycobacterium avium complex pulmonary disease. J Clin Med. 2020;9:1315.","journal-title":"J Clin Med"},{"key":"2831_CR7","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","volume":"364","author":"SE Dorman","year":"2004","unstructured":"Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon \u03b3 receptor 1 deficiencies. Lancet. 2004;364:2113\u201321.","journal-title":"Lancet"},{"key":"2831_CR8","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJM199612263352602","volume":"335","author":"MJ Newport","year":"1996","unstructured":"Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-\u03b3-receptor gene and susceptibility to mycobacterial infection. New Engl J Med. 1996;335:1941\u20139.","journal-title":"New Engl J Med"},{"key":"2831_CR9","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI19316","volume":"115","author":"B Kampmann","year":"2005","unstructured":"Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-\u03b3. J Clin Invest. 2005;115:2480\u20138.","journal-title":"J Clin Invest"},{"key":"2831_CR10","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","volume":"175","author":"SY Patel","year":"2005","unstructured":"Patel SY, Ding L, Brown MR, Lantz L, Gay T, Cohen S, et al. Anti-IFN-\u03b3 autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175:4769\u201376.","journal-title":"J Immunol"},{"key":"2831_CR11","doi-asserted-by":"publisher","first-page":"8028","DOI":"10.4049\/jimmunol.178.12.8028","volume":"178","author":"S Roque","year":"2007","unstructured":"Roque S, Nobrega C, Appelberg R, Correia-Neves M. IL-10 underlies distinct susceptibility of BALB\/c and C57BL\/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy. J Immunol. 2007;178:8028\u201335.","journal-title":"J Immunol"},{"key":"2831_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2249.1994.tb06127.x","volume":"98","author":"J Pedrosa","year":"1994","unstructured":"Pedrosa J, Florido M, Kunze ZM, Castro AG, Portaelst F, Mcfadden J. Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol. 1994;98:210\u20136.","journal-title":"Clin Exp Immunol"},{"key":"2831_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1128\/jcm.28.6.1105-1107.1990","volume":"28","author":"SE Hoffner","year":"1990","unstructured":"Hoffner SE, Kallenius G, Petrini B, Brennan PJ, Tsang AY. Serovars of Mycobacterium avium complex isolated from patients in Sweden. J Clin Microbiol. 1990;28:1105\u20137.","journal-title":"J Clin Microbiol"},{"key":"2831_CR14","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1128\/JCM.43.7.3150-3158.2005","volume":"43","author":"R Maekura","year":"2005","unstructured":"Maekura R, Okuda Y, Hirotani A, Kitada S, Hiraga T, Yoshimura K, et al. Clinical and prognostic importance of serotyping Mycobacterium avium-Mycobacterium intracellulare complex isolates in human immunodeficiency virus-negative patients. J Clin Microbiol. 2005;43:3150\u20138.","journal-title":"J Clin Microbiol"},{"key":"2831_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.micpath.2008.10.007","volume":"46","author":"Y Tateishi","year":"2009","unstructured":"Tateishi Y, Hirayama Y, Ozeki Y, Nishiuchi Y, Yoshimura M, Kang J, et al. Virulence of Mycobacterium avium complex strains isolated from immunocompetent patients. Microb Pathog. 2009;46:6\u201312.","journal-title":"Microb Pathog"},{"key":"2831_CR16","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1128\/JCM.43.9.4407-4412.2005","volume":"43","author":"XY Han","year":"2005","unstructured":"Han XY, Tarrand JJ, Infante R, Jacobson KL, Truong M. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol. 2005;43:4407\u201312.","journal-title":"J Clin Microbiol"},{"key":"2831_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.meegid.2013.12.007","volume":"21","author":"L Rindi","year":"2014","unstructured":"Rindi L, Garzelli C. Genetic diversity and phylogeny of Mycobacterium avium. Infect Genet Evol. 2014;21:375\u201383.","journal-title":"Infect Genet Evol"},{"key":"2831_CR18","doi-asserted-by":"publisher","first-page":"39750","DOI":"10.1038\/srep39750","volume":"7","author":"KI Uchiya","year":"2017","unstructured":"Uchiya KI, Tomida S, Nakagawa T, Asahi S, Nikai T, Ogawa K. Comparative genome analyses of Mycobacterium avium reveal genomic features of its subspecies and strains that cause progression of pulmonary disease. Sci Rep. 2017;7:39750.","journal-title":"Sci Rep"},{"key":"2831_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12866-021-02163-9","volume":"21","author":"Y Tateishi","year":"2021","unstructured":"Tateishi Y, Ozeki Y, Nishiyama A, Miki M, Maekura R, Fukushima Y, et al. Comparative genomic analysis of Mycobacterium intracellulare: implications for clinical taxonomic classification in pulmonary Mycobacterium avium-intracellulare complex disease. BMC Microbiol. 2021;21:103.","journal-title":"BMC Microbiol"},{"key":"2831_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00530-22","volume":"10","author":"R Maekura","year":"2022","unstructured":"Maekura R, Miki K, Tateishi Y, Matsumoto S, Kitada S, Miki M, et al. Long-term prognosis and antimycobacterial glycolipid antibody as biomarker in Mycobacterium avium-intracellulare complex pulmonary disease. Microbiol Spectr. 2022;10: e0053022.","journal-title":"Microbiol Spectr"},{"key":"2831_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/CMR.16.3.463-496.2003","volume":"16","author":"I Smith","year":"2003","unstructured":"Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003;16:463\u201396.","journal-title":"Clin Microbiol Rev"},{"key":"2831_CR22","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1172\/JCI31810","volume":"117","author":"JD Ernst","year":"2007","unstructured":"Ernst JD, Trevejo-Nu\u00f1ez G, Banaiee N. Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis. J Clin Invest. 2007;117:1738\u201345.","journal-title":"J Clin Invest"},{"key":"2831_CR23","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1186\/s12879-019-4668-x","volume":"19","author":"Y Uwamino","year":"2019","unstructured":"Uwamino Y, Nishimura T, Sato Y, Tamizu E, Asakura T, Uno S, et al. Low serum estradiol levels are related to Mycobacterium avium complex lung disease: a cross-sectional study. BMC Infect Dis. 2019;19:1055.","journal-title":"BMC Infect Dis"},{"key":"2831_CR24","doi-asserted-by":"publisher","first-page":"1902269","DOI":"10.1183\/13993003.02269-2019","volume":"58","author":"H Namkoong","year":"2021","unstructured":"Namkoong H, Omae Y, Asakura T, Ishii M, Suzuki S, Morimoto K, et al. Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease. Eur Respir J. 2021;58:1902269.","journal-title":"Eur Respir J"},{"key":"2831_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1378\/chest.09-0903","volume":"137","author":"SY Eum","year":"2010","unstructured":"Eum SY, Kong JH, Hong MS, Lee YJ, Kim JH, Hwang SH, et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest. 2010;137:122\u20138.","journal-title":"Chest"},{"key":"2831_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41385-020-0300-z","volume":"14","author":"RR Lovewell","year":"2021","unstructured":"Lovewell RR, Baer CE, Mishra BB, Smith CM, Sassetti CM. Granulocytes act as a niche for Mycobacterium tuberculosis growth. Mucosal Immunol. 2021;14:229\u201341.","journal-title":"Mucosal Immunol"},{"key":"2831_CR27","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1164\/ajrccm.160.6.9902019","volume":"160","author":"Y Yamazaki","year":"1999","unstructured":"Yamazaki Y, Kubo K, Takamizawa A, Yamamoto H, Honda T, Sone S. Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection. Am J Respir Crit Care Med. 1999;160:1851\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"2831_CR28","doi-asserted-by":"publisher","first-page":"e0190189","DOI":"10.1371\/journal.pone.0190189","volume":"13","author":"T Inomata","year":"2018","unstructured":"Inomata T, Konno S, Nagai K, Suzuki M, Nishimura M. Neutrophil predominance in bronchoalveolar lavage fluid is associated with disease severity and progression of HRCT findings in pulmonary Mycobacterium avium infection. PLoS ONE. 2018;13:e0190189.","journal-title":"PLoS ONE"},{"key":"2831_CR29","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1183\/09031936.00140913","volume":"42","author":"DM Lowe","year":"2013","unstructured":"Lowe DM, van Altena R, Klinkenberg T, Brouwers AH, Bongaerts AHH, van der Werf TS, et al. Neutrophilia independently predicts death in tuberculosis. Eur Respir J. 2013;42:1750\u20132.","journal-title":"Eur Respir J"},{"key":"2831_CR30","doi-asserted-by":"publisher","first-page":"712457","DOI":"10.3389\/fimmu.2021.712457","volume":"12","author":"C Hult","year":"2021","unstructured":"Hult C, Mattila JT, Gideon HP, Linderman JJ, Kirschner DE. Neutrophil dynamics affect Mycobacterium tuberculosis granuloma outcomes and dissemination. Front Immunol. 2021;12:712457.","journal-title":"Front Immunol"},{"key":"2831_CR31","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1172\/JCI134622","volume":"130","author":"AR DiNardo","year":"2020","unstructured":"DiNardo AR, Rajapakshe K, Nishiguchi T, Grimm SL, Mtetwa G, Dlamini Q, et al. DNA hypermethylation during tuberculosis dampens host immune responsiveness. J Clin Invest. 2020;130:3113\u201323.","journal-title":"J Clin Invest"},{"key":"2831_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Ann Rev Immunol. 2008;26:677\u2013704.","journal-title":"Ann Rev Immunol"},{"key":"2831_CR33","doi-asserted-by":"publisher","first-page":"e1005667","DOI":"10.1371\/journal.ppat.1005667","volume":"12","author":"S Sakai","year":"2016","unstructured":"Sakai S, Kauffman KD, Sallin MA, Sharpe AH, Young HA, Ganusov VV, et al. CD4 T cell-derived IFN-\u03b3 plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease. PLoS Pathog. 2016;12:e1005667.","journal-title":"PLoS Pathog"},{"key":"2831_CR34","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1038\/s41598-021-97391-4","volume":"11","author":"M Nakajima","year":"2021","unstructured":"Nakajima M, Matsuyama M, Kawaguchi M, Matsuyama S, Kiwamoto T, Matsuo Y, et al. Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium. Sci Rep. 2021;11:18008.","journal-title":"Sci Rep"},{"key":"2831_CR35","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"2831_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/intimm\/dxp126","volume":"22","author":"Y Ozeki","year":"2010","unstructured":"Ozeki Y, Sugawara I, Udagawa T, Aoki T, Osada-Oka M, Tateishi Y, et al. Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice. Int Immunol. 2010;22:179\u201389.","journal-title":"Int Immunol"},{"key":"2831_CR37","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1128\/AAC.04841-14","volume":"59","author":"C Andr\u00e9jak","year":"2015","unstructured":"Andr\u00e9jak C, Almeida DV, Tyagi S, Converse PJ, Ammerman NC, Grosset JH. Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations. Antimicrob Agents Chemother. 2015;59:2129\u201335.","journal-title":"Antimicrob Agents Chemother"},{"key":"2831_CR38","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1086\/587906","volume":"197","author":"LE Bermudez","year":"2008","unstructured":"Bermudez LE, Motamedi N, Kolonoski P, Chee C, Baimukanova G, Bildfell R, et al. The efficacy of clarithromycin and the bicyclolide EDP-420 against Mycobacterium avium in a mouse model of pulmonary infection. J Infect Dis. 2008;197:1506\u201310.","journal-title":"J Infect Dis"},{"key":"2831_CR39","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1128\/AAC.31.11.1697","volume":"31","author":"CB Inderlied","year":"1987","unstructured":"Inderlied CB, Young LS, Yamada JK. Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods. Antimicrob Agents Chemother. 1987;31:1697\u2013702.","journal-title":"Antimicrob Agents Chemother"},{"key":"2831_CR40","doi-asserted-by":"publisher","first-page":"e02349","DOI":"10.1128\/AAC.02349-19","volume":"64","author":"JP Lanoix","year":"2020","unstructured":"Lanoix JP, Joseph C, Peltier F, Castelain S, Andr\u00e9jak C. Synergistic activity of clofazimine and clarithromycin in an aerosol mouse model of Mycobacterium avium infection. Antimicrob Agents Chemother. 2020;64:e02349-e2419.","journal-title":"Antimicrob Agents Chemother"},{"key":"2831_CR41","first-page":"1290","volume":"11","author":"SL Cheng","year":"2007","unstructured":"Cheng SL, Wang HC, Yang PC. Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis. Int J Tuberclung Dis. 2007;11:1290\u20135.","journal-title":"Int J Tuberclung Dis"},{"key":"2831_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1471-2334-14-114","volume":"14","author":"T Takazono","year":"2014","unstructured":"Takazono T, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, et al. Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-\u03b1 inhibitor: a case report. BMC Infect Dis. 2014;14:114.","journal-title":"BMC Infect Dis"},{"key":"2831_CR43","first-page":"201","volume":"20","author":"S Watanabe","year":"2017","unstructured":"Watanabe S, Kaneko Y, Kawamoto H, Maehara T, Baba Y, Fujisaki I, et al. Paradoxical response with increased tumor necrosis factor-\u03b1 levels to anti-tuberculosis treatment in a patient with disseminated tuberculosis. Respir Med Case Rep. 2017;20:201\u20134.","journal-title":"Respir Med Case Rep"},{"key":"2831_CR44","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1093\/infdis\/jiaa669","volume":"223","author":"KF Breglio","year":"2021","unstructured":"Breglio KF, Vinhaes CL, Arriaga MB, Nason M, Roby G, Adelsberger J, et al. Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with human immunodeficiency virus. J Infect Dis. 2021;223:2124\u201335.","journal-title":"J Infect Dis"},{"key":"2831_CR45","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172:2731\u20138.","journal-title":"J Immunol"},{"key":"2831_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6890-3-3","volume":"3","author":"DC Doeing","year":"2003","unstructured":"Doeing DC, Borowicz JL, Crockett ET. Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods. BMC Clin Pathol. 2003;3:3.","journal-title":"BMC Clin Pathol"},{"key":"2831_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1165\/ajrcmb\/3.2.131","volume":"3","author":"R Pabst","year":"1990","unstructured":"Pabst R, Gehrke I. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am J Respir Cell Mol Biol. 1990;3:131\u20135.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2831_CR48","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1084\/jem.175.4.1111","volume":"175","author":"J Chan","year":"1992","unstructured":"Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 1992;175:1111\u201322.","journal-title":"J Exp Med"},{"key":"2831_CR49","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1126\/science.1123933","volume":"31","author":"PT Liu","year":"2006","unstructured":"Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;31:1770\u20133.","journal-title":"Science"},{"issue":"5508","key":"2831_CR50","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1126\/science.291.5508.1544","volume":"291","author":"S Thoma-Uszynski","year":"2001","unstructured":"Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 2001;291(5508):1544\u20137.","journal-title":"Science"},{"key":"2831_CR51","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1038\/s41598-020-62287-2","volume":"10","author":"Y Tateishi","year":"2020","unstructured":"Tateishi Y, Minato Y, Baughn AD, Ohnishi H, Nishiyama A, Ozeki Y, et al. Genome-wide identification of essential genes in Mycobacterium intracellulare by transposon sequencing \u2014 Implication for metabolic remodeling. Sci Rep. 2020;10:5449.","journal-title":"Sci Rep"},{"key":"2831_CR52","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.immuni.2021.08.015","volume":"54","author":"I Ullah","year":"2021","unstructured":"Ullah I, Pr\u00e9vost J, Ladinsky MS, Stone H, Lu M, Anand SP, et al. Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy. Immunity. 2021;54:2143\u201358.","journal-title":"Immunity"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02831-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-023-02831-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02831-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:21:40Z","timestamp":1680517300000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-023-02831-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2831"],"URL":"https:\/\/doi.org\/10.1186\/s12866-023-02831-y","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"7 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the Institutional Review Board of NHO Toneyama Medical Center (Approved number: TNH-2019006\u20132 for the use of human tissue samples) and Niigata University (Approved number: 2019\u20130020 for the use of human tissue samples and SA00506 for the experiments on live vertebrates). All experiments on humans and human samples were conducted in accordance with relevant guidelines and regulations. Informed consent was obtained from all patients. All experiments on animals were conducted in accordance with the relevant guidelines and regulations, and the study complied with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"According to the protocols approved by the Institutional Review Board of NHO Toneyama Medical Center and Niigata University mentioned above, consent for publication was obtained from the patients enrolled in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}